DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Grey House Partners GP Inc.
Grey House Partners GP Inc.
A group of venture funds investing in emerging and early-stage wellness, therapeutic and pharmaceutical companies around the globe.
venture manager, reported GAV $135M across 12 vehicles
Importance
30
moderate
Active deployment
0
low
Emerging
0
low
Completeness
81
high
Freshness
100
high
Research priority
3
low
Identity and regulatory footprint
- Headquarters
- Toronto, Ontario, Canadaadviserinfo.sec.gov
- Office address
- 2-87 SCOLLARD STREET, Toronto, Ontario, M5R 1G4adviserinfo.sec.gov
- Business phone
- 437-290-6200adviserinfo.sec.gov
- Website
- https://noeticfund.com/
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 27, 2024
- Private funds reported
- 12 (12 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $135Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business phone
- 437-290-6200adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- ai, healthcare, biotech, medtech, climate, space, media
- Stages
- seed, series a, early
- Geography
- asia, canada, europe, germany, global, india, u.s.
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
Other Health Care 100%
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
12 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Noetic Fund II (US), LP | Fund | 2021 form d first sale | Mature | $20.9M Mar 27, 2024 | 74 | $22.9M | Apr 19, 2024 |
| Noetic Fund II, LP | Fund | 2021 form d first sale | Mature | $15.3M Mar 27, 2024 | 42 | $3.7M | Dec 22, 2023 |
| GHP Apollo 2021 Spv LP | SPV or co-invest vehicle | 2021 name year | Mature | $598,000 Mar 27, 2024 | 5 | unknown | unknown |
| GHP Caamtech 2021 Spv LP | SPV or co-invest vehicle | 2021 name year | Mature | $549,000 Mar 27, 2024 | 12 | unknown | unknown |
| Noetic Fund II Cayman Master, LP | Feeder or parallel | unknown | Unknown | $36.1M Mar 27, 2024 | 116 | unknown | unknown |
| Noetic Psychedelic Fund LP | Fund | unknown | Unknown | $32.4M Mar 27, 2024 | 185 | unknown | unknown |
| Noetic Psychedelic Fund US LP | Fund | unknown | Unknown | $24.5M Mar 27, 2024 | 87 | unknown | unknown |
| Learn Capital IV Special Opportunities II, Ghp Mm Spv LP | SPV or co-invest vehicle | unknown | Unknown | $2.3M Mar 27, 2024 | 24 | unknown | unknown |
| Grey House Partners Eleusis Holdings Spv LP | SPV or co-invest vehicle | unknown | Unknown | $1.7M Mar 27, 2024 | 25 | unknown | unknown |
| GHP Toggle Spv LP | SPV or co-invest vehicle | unknown | Unknown | $428,000 Mar 27, 2024 | 16 | unknown | unknown |
| GHP Diamond Spv LP | SPV or co-invest vehicle | unknown | Unknown | $259,000 Mar 27, 2024 | 11 | unknown | unknown |
| GHP Vessel Health Spv LP | SPV or co-invest vehicle | unknown | Unknown | $77,000 Mar 27, 2024 | 9 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
7 current, 1 departed
David Charles Lloyd
General partnerDirector, Ghp Noetic Cayman Gp, Ltd · since Feb 1, 2021
Mark Anthony
General partnerDirector, Ghp Noetic Cayman Gp, Ltd · since Feb 1, 2021
Sa'ad Shah
PartnerManaging Director · since Nov 1, 2019
Warren Arthur Wright
PartnerManaging Director · since Mar 1, 2021
David Edward Schnarr
Platform and operationsChief Compliance Officer · since Oct 1, 2021
Richard Cheung
Platform and operationsChief Legal Counsel · since Nov 1, 2021
Teja Mullapudi
PrincipalPrincipal, Investments · since Nov 1, 2021
1 departed (kept with end dates)
- Craig Henry Hippern · Cfo And Coo · May 1, 2021 to Mar 27, 2024 Inference
Investments on record
1 edges, 1 companies, 1 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Apollo Neuroscience, Inc. | board seat | unknown · board | Sa'ad Shah (strongly supported) | unknown | unknown | Apr 29, 2024 | Inference SEC EDGAR Form D data sets (quarterly) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
14 dated events
- Mar 27, 2024Craig Henry Hippern (Cfo And Coo) no longer on Schedule A of Grey House Partners GP Inc.
- Aug 3, 2023Noetic Psychedelic Fund US LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $24,489,000Fund first reported on Form ADVFundsFactNoetic Psychedelic Fund US LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023Noetic Fund II, LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $15,327,000Fund first reported on Form ADVFundsFactNoetic Fund II, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023Grey House Partners Eleusis Holdings Spv LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $1,718,000Fund first reported on Form ADVFundsFactGrey House Partners Eleusis Holdings Spv LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023GHP Vessel Health Spv LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $77,000Fund first reported on Form ADVFundsFactGHP Vessel Health Spv LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023Noetic Psychedelic Fund LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $32,420,000Fund first reported on Form ADVFundsFactNoetic Psychedelic Fund LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023Noetic Fund II Cayman Master, LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $36,095,000Fund first reported on Form ADVFundsFactNoetic Fund II Cayman Master, LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023Grey House Partners GP Inc. first filed Form ADV (ERA)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023Noetic Fund II (US), LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $20,907,000Fund first reported on Form ADVFundsFactNoetic Fund II (US), LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023GHP Diamond Spv LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $259,000Fund first reported on Form ADVFundsFactGHP Diamond Spv LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023GHP Toggle Spv LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $428,000Fund first reported on Form ADVFundsFactGHP Toggle Spv LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023GHP Apollo 2021 Spv LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $598,000Fund first reported on Form ADVFundsFactGHP Apollo 2021 Spv LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023Learn Capital IV Special Opportunities II, Ghp Mm Spv LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $2,322,000Fund first reported on Form ADVFundsFactLearn Capital IV Special Opportunities II, Ghp Mm Spv LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Aug 3, 2023GHP Caamtech 2021 Spv LP first reported on Form ADV by Grey House Partners GP Inc. (Venture Capital Fund), GAV $549,000Fund first reported on Form ADVFundsFactGHP Caamtech 2021 Spv LPSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $135M across 12 vehicles
Evidence
28 observations from 2 sources